IFIH1 Gene

Version	Summary	Created by	Modification	Content Size	Created at	Operation
1		Dean Liu	+ 764 word(s)	764	2020-12-15 07:57:07

This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/gene/ifih1

Interferon induced with helicase C domain 1

genes

1. Introduction

The IFIH1 gene provides instructions for making the MDA5 protein, which plays an important role in innate immunity, the body's early, nonspecific response to foreign invaders (pathogens) such as viruses and bacteria. In particular, the MDA5 protein recognizes a molecule called double-stranded RNA (a chemical cousin of DNA), which certain viruses, including rhinovirus (the virus that causes the common cold), respiratory syncytial virus (RSV), and the influenza (flu) virus, have as their genetic material or produce when they infect cells and copy (replicate) themselves. (Another subset of viruses has DNA as the genetic material.) When pieces of viral RNA are present inside a cell, multiple MDA5 proteins attach to it, one after another, forming a filament. Filament formation stimulates signals that turn on the production of immune system proteins called interferons. Interferons control the activity of genes that help block the viruses from replicating themselves and stimulate the activity of certain immune system cells to fight infection. Interferons also help regulate inflammation, which is another part of the body's innate immune response.

2. Health Conditions Related to Genetic Changes

2.1. Aicardi-Goutières Syndrome

At least 12 IFIH1 gene mutations have been found in people with Aicardi-Goutières syndrome. This disorder is characterized by abnormalities of the immune system, skin, and brain, including calcium deposits in parts of the brain.

The IFIH1 gene mutations involved in Aicardi-Goutières syndrome are described as "gain-of-function" because they lead to production of an MDA5 protein with enhanced activity. The altered protein may more readily attach to RNA, even pieces of RNA that are not from viruses, or to other MDA5 proteins to form filaments. Alternatively, filaments containing the altered protein may not be broken down when immune signaling is no longer needed. As a result of these changes, interferon production is abnormally turned on, leading to excessive immune system activity and inflammation.

Constant inflammation is thought to disrupt the way calcium is handled in the body, leading to calcium deposits in people with Aicardi-Goutières syndrome. Excessive inflammation is also thought to damage cells in the brain and skin, leading to the abnormalities in these tissues characteristic of this disorder.

2.2. MDA5 Deficiency

At least four genetic changes in the IFIH1 gene have been found to cause MDA5 deficiency, an immune system disorder (immunodeficiency) that leads to recurrent, severe viral infections in the lungs and airways (respiratory tract). Infections are most commonly caused by rhinovirus, RSV, and the flu virus. The changes in the IFIH1 gene that cause this condition are described as "loss-of-function" mutations because they lead to an altered version of the MDA5 protein that cannot function. Studies suggest that the altered protein is unable to attach to viral RNA or to other MDA5 proteins to form filaments. As a result, interferon production is not turned on. A lack of the important early immune response stimulated by interferons leads to severe viral infections in infants with MDA5 deficiency.

2.3. Other Disorders

IFIH1 gene mutations have also been found to cause Singleton-Merten syndrome. A feature of Singleton-Merten syndrome is calcium deposits in the large vessel that carries blood from the heart to the rest of the body (the aorta) and in certain valves in the heart. Other signs and symptoms include tooth abnormalities, low bone density (osteopenia), and other bone problems. Some people with IFIH1 gene mutations have signs and symptoms of both Singleton-Merten syndrome and Aicardi-Goutières syndrome (described above), suggesting that these two conditions may be part of a spectrum caused by IFIH1 gene mutations.

As in Aicardi-Goutières syndrome, the IFIH1 gene mutations involved in Singleton-Merten syndrome are described as "gain-of-function" and lead to excessive immune system activity and inflammation, disrupting calcium handling in the body. It is unclear why people with gain-of-function mutations in the IFIH1 gene develop signs and symptoms of one condition or the other.

Singleton-Merten syndrome and Aicardi-Goutières syndrome both have autoimmune features, which occur when the immune system malfunctions and damages the body's own tissues and organs. Common variations (polymorphisms) in the IFIH1 gene have been associated with other autoimmune disorders. It is thought that polymorphisms that enhance the activity of the MDA5 protein increase the risk of certain autoimmune disorders, while polymorphisms that reduce the activity of the MDA5 protein help protect against others.

3. Other Names for This Gene

AGS7
CADM-140 autoantigen
clinically amyopathic dermatomyositis autoantigen 140 kDa
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide
helicard
helicase with 2 CARD domains
Hlcd
IDDM19
interferon-induced helicase C domain-containing protein 1
MDA-5
MDA5
melanoma differentiation-associated gene 5
melanoma differentiation-associated protein 5
murabutide down-regulated protein
RIG-I-like receptor 2
RLR-2
RNA helicase-DEAD box protein 116
SGMRT1

References

Asgari S, Schlapbach LJ, Anchisi S, Hammer C, Bartha I, Junier T, Mottet-OsmanG, Posfay-Barbe KM, Longchamp D, Stocker M, Cordey S, Kaiser L, Riedel T, KennaT, Long D, Schibler A, Telenti A, Tapparel C, McLaren PJ, Garcin D, Fellay J.Severe viral respiratory infections in children with IFIH1 loss-of-functionmutations. Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8342-8347. doi:10.1073/pnas.1704259114.
Berke IC, Yu X, Modis Y, Egelman EH. MDA5 assembles into a polar helicalfilament on dsRNA. Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18437-41. doi:10.1073/pnas.1212186109.
Bursztejn AC, Briggs TA, del Toro Duany Y, Anderson BH, O'Sullivan J, WilliamsSG, Bodemer C, Fraitag S, Gebhard F, Leheup B, Lemelle I, Oojageer A, Raffo E,Schmitt E, Rice GI, Hur S, Crow YJ. Unusual cutaneous features associated with a heterozygous gain-of-function mutation in IFIH1: overlap betweenAicardi-Goutières and Singleton-Merten syndromes. Br J Dermatol. 2015Dec;173(6):1505-13. doi: 10.1111/bjd.14073.
Lamborn IT, Jing H, Zhang Y, Drutman SB, Abbott JK, Munir S, Bade S, MurdockHM, Santos CP, Brock LG, Masutani E, Fordjour EY, McElwee JJ, Hughes JD, Nichols DP, Belkadi A, Oler AJ, Happel CS, Matthews HF, Abel L, Collins PL, Subbarao K,Gelfand EW, Ciancanelli MJ, Casanova JL, Su HC. Recurrent rhinovirus infectionsin a child with inherited MDA5 deficiency. J Exp Med. 2017 Jul3;214(7):1949-1972. doi: 10.1084/jem.20161759.
Loo YM, Gale M Jr. Immune signaling by RIG-I-like receptors. Immunity. 2011May 27;34(5):680-92. doi: 10.1016/j.immuni.2011.05.003. Review.
Looney BM, Xia CQ, Concannon P, Ostrov DA, Clare-Salzler MJ. Effects of type 1diabetes-associated IFIH1 polymorphisms on MDA5 function and expression. CurrDiab Rep. 2015 Nov;15(11):96. doi: 10.1007/s11892-015-0656-8. Review.
Oda H, Nakagawa K, Abe J, Awaya T, Funabiki M, Hijikata A, Nishikomori R,Funatsuka M, Ohshima Y, Sugawara Y, Yasumi T, Kato H, Shirai T, Ohara O, FujitaT, Heike T. Aicardi-Goutières syndrome is caused by IFIH1 mutations. Am J HumGenet. 2014 Jul 3;95(1):121-5. doi: 10.1016/j.ajhg.2014.06.007.
Rice GI, Del Toro Duany Y, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G,Bader-Meunier B, Baildam EM, Battini R, Beresford MW, Casarano M, Chouchane M,Cimaz R, Collins AE, Cordeiro NJ, Dale RC, Davidson JE, De Waele L, Desguerre I, Faivre L, Fazzi E, Isidor B, Lagae L, Latchman AR, Lebon P, Li C, Livingston JH, Lourenço CM, Mancardi MM, Masurel-Paulet A, McInnes IB, Menezes MP, Mignot C,O'Sullivan J, Orcesi S, Picco PP, Riva E, Robinson RA, Rodriguez D, Salvatici E, Scott C, Szybowska M, Tolmie JL, Vanderver A, Vanhulle C, Vieira JP, Webb K,Whitney RN, Williams SG, Wolfe LA, Zuberi SM, Hur S, Crow YJ. Gain-of-functionmutations in IFIH1 cause a spectrum of human disease phenotypes associated withupregulated type I interferon signaling. Nat Genet. 2014 May;46(5):503-509. doi: 10.1038/ng.2933.
Rutsch F, MacDougall M, Lu C, Buers I, Mamaeva O, Nitschke Y, Rice GI,Erlandsen H, Kehl HG, Thiele H, Nürnberg P, Höhne W, Crow YJ, Feigenbaum A,Hennekam RC. A specific IFIH1 gain-of-function mutation causes Singleton-Mertensyndrome. Am J Hum Genet. 2015 Feb 5;96(2):275-82. doi:10.1016/j.ajhg.2014.12.014.
Van Eyck L, De Somer L, Pombal D, Bornschein S, Frans G, Humblet-Baron S,Moens L, de Zegher F, Bossuyt X, Wouters C, Liston A. Brief Report: IFIH1Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency.Arthritis Rheumatol. 2015 Jun;67(6):1592-7. doi: 10.1002/art.39110.

©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.

Upload a video for this entry

Information

Subjects: Genetics & Heredity

Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :

Dean Liu

View Times: 433

Entry Collection: MedlinePlus

Update Date: 23 Dec 2020

Table of Contents

Video Upload Options

Confirm